Healthcare - Biotechnology - NASDAQ - US
$ 8.9
-7.77 %
$ 983 M
Market Cap
-3.59
P/E
CASH FLOW STATEMENT
-154 M
OPERATING CASH FLOW
-97.8 M
INVESTING CASH FLOW
164 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cogent Biosciences, Inc.
| Net Income | -192 M |
| Depreciation & Amortization | 3.59 M |
| Capital Expenditures | -2.8 M |
| Stock-Based Compensation | 30.6 M |
| Change in Working Capital | 11.4 M |
| Others | -236 K |
| Free Cash Flow | -156 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (192.4) | (140.2) | (72.3) | (74.8) | (31.8) | (34.5) | (25.5) | (18.1) | (6.6) |
| Depreciation & Amortization | 3.6 | 5.9 | 0.1 | 0.7 | 1.3 | 1.3 | 1.2 | 0.8 | 0.2 |
| Deferred Income Tax | 0 | 0 | 0 | (7.5) | 0 | (0.2) | 17 K | 17 K | (0.2) |
| Stock Based Compensation | 30.6 | 18.4 | 11.7 | 6.0 | 3.2 | 3.1 | 1.3 | 1.0 | 0.2 |
| Other Operating Activities | (6.9) | (3.4) | (0.3) | 45.0 | (0.1) | 23 K | 7 K | 56 K | 0.2 |
| Change in Working Capital | 11.4 | 0.8 | 2.0 | (5.3) | (14.1) | (2.2) | (2.9) | (2.3) | 23.9 |
| Cash From Operations | (153.6) | (118.6) | (58.8) | (35.9) | (41.5) | (32.5) | (25.8) | (18.6) | 17.7 |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (2.8) | (6.9) | (1.7) | 0 | 33 K | (0.5) | (0.9) | (3.3) | (2.0) |
| Other Items | (95.0) | (117.9) | 0 | 8.4 | 23.2 | (10.0) | 14.4 | (27.1) | (1.3) |
| Cash From Investing Activities | (97.8) | (124.7) | (1.7) | 8.4 | 23.2 | (10.5) | 13.5 | (30.4) | (3.2) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.7 | 1.6 | 30 K | 99.5 | 0.1 | (1.4) | (0.8) | 40 K | 70.8 |
| Cash From Financing Activities | 163.5 | 163.6 | 38.0 | 232.2 | 0.1 | 70.3 | (0.7) | 40 K | 70.8 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | (87.9) | (79.8) | (22.5) | 204.8 | (18.2) | 27.3 | (13.1) | (49.1) | 85.2 |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (156.4) | (125.5) | (60.5) | (35.9) | (41.5) | (33.0) | (26.7) | (21.9) | 15.7 |